Wednesday, May 23, 2018 6:17:53 PM
I know that igotthemojo can answer this. How pertinent do you feel the technicals really are for a stock like this? The "traditional" investment community really isn't paying attention at all, and I would think KBLB would get tossed by most search/filter inquiries that most investors have set up. This really seems to me to be a stock who's price will move entirely on news, and new, bigger, brighter, pretty investors won't appear until revenues are realised. Comments by any and all are welcome. Didn't mean only mojo's thoughts counted.
I think real revenue, not income, I mean simple cash flow, of any importance is still quite a ways off. I think just about everybody that approaches KBLB will do as the U.S. Army did. Look at MS or DS, ask if a tweek can be made here and there, and then sign an R+D agreement. I don't see a lot of MS or DS just being sold right off the reel. Customization will be very appealing to just about every one, which makes this PR that much more interesting.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM